Skip to content

Pencis

Pencis

close
  • Home
  • Submit Abstract
  • Registration
  • Program
    • Brouchure
    • Speakers
    • Terms & Conditions
    • Schedule
  • Awards
  • About
    • Call for abstracts
    • Sponsorship
    • Exhibitions
  • Help
  • English
    Arabic Chinese (Simplified) Dutch English German Italian Portuguese Russian Spanish

Category: News

  • Home
  • News

Alopecia Areata Significantly Associated With Various Inflammatory … – Dermatology Advisor

Posted on 23/03/2023 by PencisLeave a Comment on Alopecia Areata Significantly Associated With Various Inflammatory … – Dermatology Advisor



Alopecia Areata Significantly Associated With Various Inflammatory …  Dermatology Advisor



Source link

Posted in: News

Oleogel-S10 for Epidermolysis Bullosa Wounds Demonstrated … – Dermatology Times

Posted on 23/03/2023 by PencisLeave a Comment on Oleogel-S10 for Epidermolysis Bullosa Wounds Demonstrated … – Dermatology Times



Oleogel-S10 for Epidermolysis Bullosa Wounds Demonstrated …  Dermatology Times



Source link

Posted in: News

Latinx, Hispanic Patients with Alopecia Carry Greater Disease … – Dermatology Times

Posted on 23/03/2023 by PencisLeave a Comment on Latinx, Hispanic Patients with Alopecia Carry Greater Disease … – Dermatology Times



Latinx, Hispanic Patients with Alopecia Carry Greater Disease …  Dermatology Times



Source link

Posted in: News

Oral Vitamin D Supplementation May Lower Melanoma Risk – Dermatology Times

Posted on 23/03/2023 by PencisLeave a Comment on Oral Vitamin D Supplementation May Lower Melanoma Risk – Dermatology Times



Oral Vitamin D Supplementation May Lower Melanoma Risk  Dermatology Times



Source link

Posted in: News

Search

Recent Posts

  • Alopecia Areata Significantly Associated With Various Inflammatory … – Dermatology Advisor
  • Oleogel-S10 for Epidermolysis Bullosa Wounds Demonstrated … – Dermatology Times
  • Latinx, Hispanic Patients with Alopecia Carry Greater Disease … – Dermatology Times
  • Oral Vitamin D Supplementation May Lower Melanoma Risk – Dermatology Times
  • Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers

Recent Comments

    Archives

    • March 2023
    • February 2023

    Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Latest News

    Pencis welcomes researchers from Dermatology and Cosmetology field to be a part of our Pencis. Join our international community and exchange your knowlegde with the experts and professionals from your field of Research.
    Announcement: All accepted papers will be included in the conference proceedings, which will be published in one of the author Pencis journals.
    RECOMMENDED

    Dermatology 2023 San Francisco, United States | Dermatology 2023 Berlin, Germany | Dermatology 2023 Paris, France | Dermatology 2023 Dubai, United Arab Emirates | Dermatology 2024 Amsterdam,Netherlands

    Social Media

    Mail us

    Drop us an email for Event  Enquiry:
    dermatology@pencis.com

    General / Sponsors / Exhibiting / Advertising:
    contact@pencis.com

    Contact

    Office Login Only

    Register
    Forgot Password?
    Copyright © 2023 Pencis. All rights reserved. Theme Suffice by ThemeGrill. Powered by: WordPress.

    Pencis

    close
    • Home
    • Submit Abstract
    • Registration
    • Program
      • Brouchure
      • Speakers
      • Terms & Conditions
      • Schedule
    • Awards
    • About
      • Call for abstracts
      • Sponsorship
      • Exhibitions
    • Help
    • English
      Arabic Chinese (Simplified) Dutch English German Italian Portuguese Russian Spanish